[HTML][HTML] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer… - Journal of …, 2015 - Elsevier
Background & Aims Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
[PDF][PDF] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer, E Montanari… - researchgate.net
Background & Aims: Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice.
RP Meier, R Mahou, P Morel, J Meyer… - Journal of …, 2015 - folia.unifr.ch
METHODS Human bone marrow-derived MSCs were microencapsulated in novel alginate-
polyethylene glycol microspheres. In vitro, we analyzed the effect of MSC-conditioned …
polyethylene glycol microspheres. In vitro, we analyzed the effect of MSC-conditioned …
[PDF][PDF] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer, E Montanari… - access.archive-ouverte.unige.ch
Background & Aims: Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Background & aims Mesenchymal stem cell (MSC) transplantation was shown to be effective
for the treatment of liver fibrosis, but the mechanisms of action are not yet fully understood …
for the treatment of liver fibrosis, but the mechanisms of action are not yet fully understood …
[PDF][PDF] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer, E Montanari… - 2014 - hug.ch
Background & Aims: Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
[引用][C] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer… - Journal of …, 2015 - cir.nii.ac.jp
[PDF][PDF] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
core.ac.uk
Background & Aims: Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
[HTML][HTML] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer… - Journal of …, 2015 - journal-of-hepatology.eu
Background & Aims Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
[PDF][PDF] Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
RPH Meier, R Mahou, P Morel, J Meyer, E Montanari… - cyberleninka.org
Background & Aims: Mesenchymal stem cell (MSC) transplantation was shown to be
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
effective for the treatment of liver fibrosis, but the mechanisms of action are not yet fully …
